(MAR) Marriott International - Ratings and Ratios
Hotels, Resorts, Residences, Timeshares, Lodging
Dividends
| Dividend Yield | 0.90% |
| Yield on Cost 5y | 2.06% |
| Yield CAGR 5y | 49.69% |
| Payout Consistency | 57.6% |
| Payout Ratio | 26.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.7% |
| Value at Risk 5%th | 39.4% |
| Relative Tail Risk | -3.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -11.89 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 1.061 |
| Beta Downside | 1.018 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.50% |
| Mean DD | 6.63% |
| Median DD | 5.75% |
Description: MAR Marriott International December 02, 2025
Marriott International, Inc. (NASDAQ: MAR) operates, franchises, and licenses a diversified portfolio of lodging assets-including hotels, residential units, timeshares, and even yachts-across more than 130 countries. Its brand suite spans the ultra-luxury segment (JW Marriott, The Ritz-Carlton, St. Regis, EDITION, Bvlgari) to mid-scale and select-service labels (Courtyard, Fairfield, Residence Inn, Moxy, etc.), and it maintains a loyalty ecosystem under the Marriott Bonvoy program. Founded in 1927, the company is headquartered in Bethesda, Maryland.
Key recent metrics indicate that Marriott’s 2023 RevPAR grew ~6 % year-over-year, driven by a 4 % lift in average daily rate (ADR) and a modest 2 % rise in occupancy despite higher inflationary pressures. The pipeline now includes roughly 1,200 hotels slated to open through 2026, with a particular emphasis on asset-light franchising in high-growth markets such as Asia-Pacific and the Middle East. Macro-level drivers remain robust leisure travel demand, a tightening labor market that pressures operating costs, and the sensitivity of discretionary spending to real-interest-rate movements. For a deeper dive into Marriott’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (2.61b TTM) > 0 and > 6% of Revenue (6% = 1.56b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -18.08% (prev -19.97%; Δ 1.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 2.70b > Net Income 2.61b (YES >=105%, WARN >=100%) |
| Net Debt (16.21b) to EBITDA (4.71b) ratio: 3.44 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (272.7m) change vs 12m ago -3.14% (target <= -2.0% for YES) |
| Gross Margin 21.68% (prev 20.47%; Δ 1.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 95.94% (prev 94.49%; Δ 1.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.37 (EBITDA TTM 4.71b / Interest Expense TTM 781.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.66
| (A) -0.17 = (Total Current Assets 4.11b - Total Current Liabilities 8.80b) / Total Assets 27.83b |
| (B) 0.65 = Retained Earnings (Balance) 18.15b / Total Assets 27.83b |
| (C) 0.16 = EBIT TTM 4.19b / Avg Total Assets 27.02b |
| (D) 0.56 = Book Value of Equity 17.48b / Total Liabilities 30.95b |
| Total Rating: 2.66 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.70
| 1. Piotroski 5.0pt |
| 2. FCF Yield 2.25% |
| 3. FCF Margin 8.55% |
| 4. Debt/Equity -5.41 |
| 5. Debt/Ebitda 3.44 |
| 6. ROIC - WACC (= 16.71)% |
| 7. RoE -85.31% |
| 8. Rev. Trend 85.74% |
| 9. EPS Trend 75.32% |
What is the price of MAR shares?
Over the past week, the price has changed by -4.00%, over one month by +3.61%, over three months by +10.80% and over the past year by +1.01%.
Is MAR a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 16
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the MAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 291.9 | -0.2% |
| Analysts Target Price | 291.9 | -0.2% |
| ValueRay Target Price | 347.8 | 18.9% |
MAR Fundamental Data Overview December 03, 2025
P/E Trailing = 32.0422
P/E Forward = 26.178
P/S = 11.983
P/B = 47.4452
P/EG = 1.6447
Beta = 1.171
Revenue TTM = 25.93b USD
EBIT TTM = 4.19b USD
EBITDA TTM = 4.71b USD
Long Term Debt = 14.44b USD (from longTermDebt, last quarter)
Short Term Debt = 1.56b USD (from shortTermDebt, last quarter)
Debt = 16.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.21b USD (from netDebt column, last quarter)
Enterprise Value = 98.58b USD (82.37b + Debt 16.89b - CCE 678.0m)
Interest Coverage Ratio = 5.37 (Ebit TTM 4.19b / Interest Expense TTM 781.0m)
FCF Yield = 2.25% (FCF TTM 2.22b / Enterprise Value 98.58b)
FCF Margin = 8.55% (FCF TTM 2.22b / Revenue TTM 25.93b)
Net Margin = 10.07% (Net Income TTM 2.61b / Revenue TTM 25.93b)
Gross Margin = 21.68% ((Revenue TTM 25.93b - Cost of Revenue TTM 20.30b) / Revenue TTM)
Gross Margin QoQ = 21.94% (prev 26.87%)
Tobins Q-Ratio = 3.54 (Enterprise Value 98.58b / Total Assets 27.83b)
Interest Expense / Debt = 1.22% (Interest Expense 206.0m / Debt 16.89b)
Taxrate = 26.76% (266.0m / 994.0m)
NOPAT = 3.07b (EBIT 4.19b * (1 - 26.76%))
Current Ratio = 0.47 (Total Current Assets 4.11b / Total Current Liabilities 8.80b)
Debt / Equity = -5.41 (negative equity) (Debt 16.89b / totalStockholderEquity, last quarter -3.12b)
Debt / EBITDA = 3.44 (Net Debt 16.21b / EBITDA 4.71b)
Debt / FCF = 7.31 (Net Debt 16.21b / FCF TTM 2.22b)
Total Stockholder Equity = -3.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.38% (Net Income 2.61b / Total Assets 27.83b)
RoE = -85.31% (negative equity) (Net Income TTM 2.61b / Total Stockholder Equity -3.06b)
RoCE = 36.82% (EBIT 4.19b / Capital Employed (Equity -3.06b + L.T.Debt 14.44b))
RoIC = 25.10% (NOPAT 3.07b / Invested Capital 12.23b)
WACC = 8.39% (E(82.37b)/V(99.26b) * Re(9.93%) + D(16.89b)/V(99.26b) * Rd(1.22%) * (1-Tc(0.27)))
Discount Rate = 9.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.96%
[DCF Debug] Terminal Value 73.13% ; FCFE base≈2.39b ; Y1≈2.60b ; Y5≈3.26b
Fair Price DCF = 153.7 (DCF Value 41.24b / Shares Outstanding 268.4m; 5y FCF grow 9.96% → 3.0% )
EPS Correlation: 75.32 | EPS CAGR: 18.67% | SUE: 0.18 | # QB: 0
Revenue Correlation: 85.74 | Revenue CAGR: 10.61% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.49 | Chg30d=-0.009 | Revisions Net=-2 | Analysts=17
EPS next Year (2026-12-31): EPS=11.38 | Chg30d=+0.033 | Revisions Net=+2 | Growth EPS=+12.6% | Growth Revenue=+5.0%
Additional Sources for MAR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle